A detailed history of Marshall Wace, LLP transactions in Clover Health Investments, Corp. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,408,863 shares of CLOV stock, worth $4.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,408,863
Previous 44,856 3040.86%
Holding current value
$4.4 Million
Previous $55,000 7096.36%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.2 - $3.5 $1.64 Million - $4.77 Million
1,364,007 Added 3040.86%
1,408,863 $3.96 Million
Q2 2024

Aug 14, 2024

BUY
$0.62 - $1.31 $27,810 - $58,761
44,856 New
44,856 $55,000
Q1 2022

May 16, 2022

SELL
$2.01 - $4.05 $2.5 Million - $5.04 Million
-1,245,630 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.72 - $8.12 $4.63 Million - $10.1 Million
1,245,630 New
1,245,630 $4.63 Million

Others Institutions Holding CLOV

About CLOVER HEALTH INVESTMENTS, CORP.


  • Ticker CLOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 383,248,000
  • Market Cap $1.2B
  • Description
  • Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health In...
More about CLOV
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.